Matches in Wikidata for { <http://www.wikidata.org/entity/Q94587535> ?p ?o ?g. }
Showing items 1 to 37 of
37
with 100 items per page.
- Q94587535 description "artículu científicu espublizáu en marzu de 2020" @default.
- Q94587535 description "scientific article published on 08 March 2020" @default.
- Q94587535 description "wetenschappelijk artikel" @default.
- Q94587535 description "наукова стаття, опублікована 8 березня 2020" @default.
- Q94587535 name "Pembrolizumab for Previously Treated, PD-L1-expressing Advanced NSCLC: Real-world Time on Treatment and Overall Survival" @default.
- Q94587535 name "Pembrolizumab for Previously Treated, PD-L1-expressing Advanced NSCLC: Real-world Time on Treatment and Overall Survival" @default.
- Q94587535 type Item @default.
- Q94587535 label "Pembrolizumab for Previously Treated, PD-L1-expressing Advanced NSCLC: Real-world Time on Treatment and Overall Survival" @default.
- Q94587535 label "Pembrolizumab for Previously Treated, PD-L1-expressing Advanced NSCLC: Real-world Time on Treatment and Overall Survival" @default.
- Q94587535 prefLabel "Pembrolizumab for Previously Treated, PD-L1-expressing Advanced NSCLC: Real-world Time on Treatment and Overall Survival" @default.
- Q94587535 prefLabel "Pembrolizumab for Previously Treated, PD-L1-expressing Advanced NSCLC: Real-world Time on Treatment and Overall Survival" @default.
- Q94587535 P1433 Q94587535-ABB34264-622C-489C-A024-459986BFB4E8 @default.
- Q94587535 P1476 Q94587535-560496A2-7F70-42FC-A407-DC025FDF6388 @default.
- Q94587535 P2093 Q94587535-3B62A97D-8C08-4BBE-B07A-2607F921D03B @default.
- Q94587535 P2093 Q94587535-49B828BF-70FA-4DFF-83DC-E039C08D2A18 @default.
- Q94587535 P2093 Q94587535-7F59086B-6730-41E4-9B55-06894DE16C82 @default.
- Q94587535 P2093 Q94587535-A308B95F-B8BB-4CBA-83FA-C0CFDAE5D28E @default.
- Q94587535 P2093 Q94587535-D27C717A-EF87-4ECC-BF2E-86136D84C736 @default.
- Q94587535 P31 Q94587535-369AF6AF-08F2-4743-9BDC-7EDFC2E81A59 @default.
- Q94587535 P356 Q94587535-B04DB24F-2AF8-4D42-A3C5-98CBEBE1D26D @default.
- Q94587535 P577 Q94587535-03E47F70-14E6-44EF-A7CC-3907C0DF886F @default.
- Q94587535 P698 Q94587535-AB891446-3425-424B-A7D7-DAD37049452B @default.
- Q94587535 P921 Q94587535-B29FE5B4-B8B5-4165-8EE2-182956908F2E @default.
- Q94587535 P356 J.CLLC.2020.02.023 @default.
- Q94587535 P698 32376116 @default.
- Q94587535 P1433 Q332299 @default.
- Q94587535 P1476 "Pembrolizumab for Previously Treated, PD-L1-expressing Advanced NSCLC: Real-world Time on Treatment and Overall Survival" @default.
- Q94587535 P2093 "Bilal Piperdi" @default.
- Q94587535 P2093 "Sheenu Chandwani" @default.
- Q94587535 P2093 "Thomas Burke" @default.
- Q94587535 P2093 "Vamsidhar Velcheti" @default.
- Q94587535 P2093 "Xin Chen" @default.
- Q94587535 P31 Q13442814 @default.
- Q94587535 P356 "10.1016/J.CLLC.2020.02.023" @default.
- Q94587535 P577 "2020-03-08T00:00:00Z" @default.
- Q94587535 P698 "32376116" @default.
- Q94587535 P921 Q13896859 @default.